Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Translating antibody insights.

Gerberding JL.

Science. 2013 Sep 13;341(6151):1151. doi: 10.1126/science.1245018. No abstract available.

2.

The new vaccine frontier.

Gerberding JL.

S D Med. 2013;Spec no:123-6. Review.

PMID:
23444603
3.

Healthcare epidemiology: past and future.

Gerberding JL.

Infect Control Hosp Epidemiol. 2010 Nov;31 Suppl 1:S73-5. doi: 10.1086/656003.

PMID:
20929378
4.

Influenza in 2009: new solutions, same old problems.

Gerberding JL.

JAMA. 2009 Nov 4;302(17):1907-8. doi: 10.1001/jama.2009.1617. No abstract available.

PMID:
19887666
5.

Safer fats for healthier hearts: the case for eliminating dietary artificial trans fat intake.

Gerberding JL.

Ann Intern Med. 2009 Jul 21;151(2):137-8. No abstract available.

PMID:
19620167
6.

Case records of the Massachusetts General Hospital. Case 34-2008. A 58-year-old woman with neck pain and fever.

Gerberding JL, Romero JM, Ferraro MJ.

N Engl J Med. 2008 Oct 30;359(18):1942-9. doi: 10.1056/NEJMcpc0806980. No abstract available.

PMID:
18971496
7.

Streptococcus suis meningitis, United States.

Lee GT, Chiu CY, Haller BL, Denn PM, Hall CS, Gerberding JL.

Emerg Infect Dis. 2008 Jan;14(1):183-5. doi: 10.3201/eid1401.070930. No abstract available.

8.

Pandemic preparedness: pigs, poultry, and people versus plans, products, and practice.

Gerberding JL.

J Infect Dis. 2006 Nov 1;194 Suppl 2:S77-81.

PMID:
17163393
9.

Measuring the public's health.

Thacker SB, Stroup DF, Carande-Kulis V, Marks JS, Roy K, Gerberding JL.

Public Health Rep. 2006 Jan-Feb;121(1):14-22.

10.

Flu virus will not be sent in the regular US mail.

Gerberding JL.

Nature. 2005 Dec 8;438(7069):738. No abstract available.

PMID:
16340988
11.

Protecting health--the new research imperative.

Gerberding JL.

JAMA. 2005 Sep 21;294(11):1403-6. No abstract available.

PMID:
16174702
12.

Management of occupational and nonoccupational postexposure HIV prophylaxis.

Katz MH, Gerberding JL.

Curr HIV/AIDS Rep. 2004 Dec;1(4):159-65. Review.

PMID:
16091237
13.

Women and infectious diseases.

Gerberding JL.

Emerg Infect Dis. 2004 Nov;10(11):1965-7. No abstract available.

14.

Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area.

Eguia JM, Liu C, Moore M, Wrone EM, Pont J, Gerberding JL, Chambers HF.

Clin Infect Dis. 2005 Jun 1;40(11):1617-24. Epub 2005 Apr 19.

PMID:
15889359
15.

Plenary session 4: Improving health, eliminating disparities: visions for the 21st century.

Gerberding JL.

Ethn Dis. 2005 Spring;15(2 Suppl 2):S78-80. No abstract available.

PMID:
15822845
16.

Correction: actual causes of death in the United States, 2000.

Mokdad AH, Marks JS, Stroup DF, Gerberding JL.

JAMA. 2005 Jan 19;293(3):293-4. No abstract available.

PMID:
15657315
17.

Making America fit and trim--steps big and small.

Gerberding JL, Marks JS.

Am J Public Health. 2004 Sep;94(9):1478-9. Review. No abstract available.

18.

Assessing the status of infection control programs in small rural hospitals in the western United States.

Stevenson KB, Murphy CL, Samore MH, Hannah EL, Moore JW, Barbera J, Houck P, Gerberding JL.

Am J Infect Control. 2004 Aug;32(5):255-61.

PMID:
15292888
19.

Pharmacist involvement in antimicrobial use at rural community hospitals in four Western states.

Stevenson KB, Samore M, Barbera J, Hannah E, Moore JW, Gerberding JL, Houck P.

Am J Health Syst Pharm. 2004 Apr 15;61(8):787-92.

PMID:
15127962
20.
21.

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 9-2004. An 18-year-old man with respiratory symptoms and shock.

Gerberding JL, Morgan JG, Shepard JA, Kradin RL.

N Engl J Med. 2004 Mar 18;350(12):1236-47. No abstract available.

22.

Actual causes of death in the United States, 2000.

Mokdad AH, Marks JS, Stroup DF, Gerberding JL.

JAMA. 2004 Mar 10;291(10):1238-45. Review. Erratum in: JAMA. 2005 Jan 19;293(3):298. Erratum in: JAMA. 2005 Jan 19;293(3):293-4.

PMID:
15010446
23.

Julie Louise Gerberding--director of the Centers for Disease Control and Prevention. Interview by Pam Das.

Gerberding JL.

Lancet Infect Dis. 2004 Mar;4(3):178-81. No abstract available.

PMID:
14998505
24.

Foreword. Public health law, 2002-2003: year of achievement.

Gerberding JL, Moulton AD, Goodman RA, Ransom MM.

J Law Med Ethics. 2003 Winter;31(4):482-4. No abstract available.

25.

Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards.

Stevenson KB, Samore M, Barbera J, Moore JW, Hannah E, Houck P, Tenover FC, Gerberding JL.

Diagn Microbiol Infect Dis. 2003 Sep;47(1):303-11.

PMID:
12967743
26.

Medicine. The need for a global HIV vaccine enterprise.

Klausner RD, Fauci AS, Corey L, Nabel GJ, Gayle H, Berkley S, Haynes BF, Baltimore D, Collins C, Douglas RG, Esparza J, Francis DP, Ganguly NK, Gerberding JL, Johnston MI, Kazatchkine MD, McMichael AJ, Makgoba MW, Pantaleo G, Piot P, Shao Y, Tramont E, Varmus H, Wasserheit JN.

Science. 2003 Jun 27;300(5628):2036-9.

PMID:
12829768
27.

Faster... but fast enough? Responding to the epidemic of severe acute respiratory syndrome.

Gerberding JL.

N Engl J Med. 2003 May 15;348(20):2030-1. Epub 2003 Apr 2. No abstract available.

28.

Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization.

Pessoa-Silva CL, Meurer Moreira B, Câmara Almeida V, Flannery B, Almeida Lins MC, Mello Sampaio JL, Martins Teixeira L, Vaz Miranda LE, Riley LW, Gerberding JL.

J Hosp Infect. 2003 Mar;53(3):198-206.

PMID:
12623321
29.

Clinical practice. Occupational exposure to HIV in health care settings.

Gerberding JL.

N Engl J Med. 2003 Feb 27;348(9):826-33. Review. No abstract available.

PMID:
12606738
30.

A comprehensive approach to percutaneous injury prevention during phlebotomy: results of a multicenter study, 1993-1995.

Alvarado-Ramy F, Beltrami EM, Short LJ, Srivastava PU, Henry K, Mendelson M, Gerberding JL, Delclos GL, Campbell S, Solomon R, Fahrner R, Culver DH, Bell D, Cardo DM, Chamberland ME.

Infect Control Hosp Epidemiol. 2003 Feb;24(2):97-104.

PMID:
12602691
31.

Patient safety and the science of prevention: the time for implementing the Guidelines for the prevention of intravascular catheter-related infections is now.

O'Grady NP, Gerberding JL, Weinstein RA, Masur H.

Crit Care Med. 2003 Jan;31(1):291-2. No abstract available.

PMID:
12545031
32.

Guidelines for the prevention of intravascular catheter-related infections.

O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA; Healthcare Infection Control Practices Advisory Committee.

Infect Control Hosp Epidemiol. 2002 Dec;23(12):759-69.

PMID:
12517020
33.

Guidelines for the prevention of intravascular catheter-related infections.

O'grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA; Healthcare Infection Control Practices Advisory Committee.

Am J Infect Control. 2002 Dec;30(8):476-89. Review.

PMID:
12461511
34.

Management of Occupational and Nonoccupational Postexposure HIV Prophylaxis.

Katz MH, Gerberding JL.

Curr Infect Dis Rep. 2002 Dec;4(6):543-549.

PMID:
12433332
35.

Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S.

O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA.

Pediatrics. 2002 Nov;110(5):e51.

PMID:
12415057
36.

Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital.

Winston LG, Bangsberg DR, Chambers HF 3rd, Felt SC, Rosen JI, Charlebois ED, Wong M, Steele L, Gerberding JL, Perdreau-Remington F.

Am J Infect Control. 2002 Nov;30(7):400-6.

PMID:
12410216
37.

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.

Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, Cetron M, Cohen M, Doyle T, Fischer M, Greene C, Griffith KS, Guarner J, Hadler JL, Hayslett JA, Meyer R, Petersen LR, Phillips M, Pinner R, Popovic T, Quinn CP, Reefhuis J, Reissman D, Rosenstein N, Schuchat A, Shieh WJ, Siegal L, Swerdlow DL, Tenover FC, Traeger M, Ward JW, Weisfuse I, Wiersma S, Yeskey K, Zaki S, Ashford DA, Perkins BA, Ostroff S, Hughes J, Fleming D, Koplan JP, Gerberding JL; National Anthrax Epidemiologic Investigation Team.

Emerg Infect Dis. 2002 Oct;8(10):1019-28.

38.

Anthrax bioterrorism: lessons learned and future directions.

Hughes JM, Gerberding JL.

Emerg Infect Dis. 2002 Oct;8(10):1013-4. No abstract available.

39.

Hospital-onset infections: a patient safety issue.

Gerberding JL.

Ann Intern Med. 2002 Oct 15;137(8):665-70.

PMID:
12379067
40.

Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA.

MMWR Recomm Rep. 2002 Aug 9;51(RR-10):1-29.

41.

Nurse staffing and healthcare-associated infections: proceedings from a working group meeting.

Jackson M, Chiarello LA, Gaynes RP, Gerberding JL.

J Nurs Adm. 2002 Jun;32(6):314-22.

PMID:
12055487
42.

Nurse staffing and health care-associated infections: Proceedings from a working group meeting.

Jackson M, Chiarello LA, Gaynes RP, Gerberding JL.

Am J Infect Control. 2002 Jun;30(4):199-206.

PMID:
12032494
43.

Bioterrorism preparedness and response: clinicians and public health agencies as essential partners.

Gerberding JL, Hughes JM, Koplan JP.

JAMA. 2002 Feb 20;287(7):898-900. No abstract available.

PMID:
11851584
44.

Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnell M, Guarner J, Shieh WJ, Malecki JM, Gerberding JL, Hughes JM, Perkins BA; Anthrax Bioterrorism Investigation Team.

Emerg Infect Dis. 2001 Nov-Dec;7(6):933-44.

45.

Issues and opportunities in public health informatics: a panel discussion.

Kukafka R, O'Carroll PW, Gerberding JL, Shortliffe EH, Aliferis C, Lumpkin JR, Yasnoff WA.

J Public Health Manag Pract. 2001 Nov;7(6):31-42.

PMID:
11710167
46.

HIV incidence among repeat HIV testers at a county hospital, San Francisco, California, USA.

Kellogg TA, McFarland W, Perlman JL, Weinstock H, Bock S, Katz MH, Gerberding JL, Bangsberg DR.

J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):59-64.

PMID:
11579278
47.

Health-care quality promotion through infection prevention: beyond 2000.

Gerberding JL.

Emerg Infect Dis. 2001 Mar-Apr;7(2):363-6.

48.

Clinical infection control in gene therapy: a multidisciplinary conference.

Evans ME, Jordan CT, Chang SM, Conrad C, Gerberding JL, Kaufman HL, Mayhall CG, Nolta JA, Pilaro AM, Sullivan S, Weber DJ, Wivel NA.

Infect Control Hosp Epidemiol. 2000 Oct;21(10):659-73. Review.

PMID:
11083185
49.

"Sputum aeruginosa": time to rewrite the textbooks on virus-induced airway inflammation.

Gerberding JL.

Am J Med. 2000 Jan;108(1):91-2. No abstract available.

PMID:
11059447
50.

Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.

Martin JN, Rose DA, Hadley WK, Perdreau-Remington F, Lam PK, Gerberding JL.

J Infect Dis. 1999 Dec;180(6):1809-18.

PMID:
10558935

Supplemental Content

Loading ...
Support Center